Emerging biotechs and their investors are exploring partnerships with drug companies at much earlier stages. Experts at ...

Policy pressure, affordability gaps, and consumer expectations are reshaping how pharma companies think about direct to ...

Firm consolidation, thoughtful staffing, disciplined scope control, and performance accountability can save life sciences ...